Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 6/20 | 0.58 |
| ▸ | CNR2 | P34972 | 5/20 | 0.58 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.43 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
| ▸ | PDE5A | O76074 | 2/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1749136 | 0.93 | CNR1 (0.65) | CNR1CNR2PRKCZNR3C2KIF11 | |
| SCHEMBL31588979 | 0.93 | CNR1 (0.65) | CNR1CNR2PRKCZNR3C2KIF11 | |
| SCHEMBL12640009 | 0.93 | CNR1 (0.65) | CNR1CNR2PRKCZNR3C2KIF11 | |
| SCHEMBL14396605 | 0.91 | CNR1 (0.58) | CNR1CNR2PRKCZNR3C2KIF11 | |
| SCHEMBL14395009 | 0.91 | CNR1 (0.58) | CNR1CNR2PRKCZNR3C2KIF11 | |
| SCHEMBL2020884 | 0.88 | CNR1 (0.58) | CNR1CNR2NR3C2KIF11GABRA2 | |
| SCHEMBL2021047 | 0.88 | CNR1 (0.58) | CNR1CNR2NR3C2EGFR | |
| SCHEMBL2024421 | 0.85 | CNR1 (0.55) | CNR1CNR2PDE5AEGFR | |
| SCHEMBL2991907 | 0.84 | CNR1 (0.64) | CNR1CNR2PRKCZNR3C2KIF11 | |
| SCHEMBL8472104 | 0.84 | CNR1 (0.55) | CNR1CNR2PRKCZNR3C2PDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7994200-B2 | Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2011-08-09 | — | — | US | disclosed |
| EP-1849776-A1 | Azepane- or Azocane-substituted pyrazoline compounds, their preparation and use as medicaments | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-10-31 | — | — | EP | disclosed |
| EP-1849775-A1 | Cycloalkane-substituted pyrazoline compounds, their preparation and use as medicaments | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-10-31 | — | — | EP | disclosed |
| EP-1849783-A1 | Octahydropentalene-substituted pyrazoline compounds, their preparation and use as medicaments | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-10-31 | — | — | EP | disclosed |
| EP-1849784-A1 | Indoline-substituted pyrazoline compounds, their preparation and use as medicaments | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-10-31 | — | — | EP | disclosed |
| WO-2007009724-A2 | CYCLOALKANE-SUBSTITUTED PYRAZOLINE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS | LABORATORIES DEL DR. ESTEVE, S.A. (ES) | 2007-01-25 | — | — | WO | disclosed |